J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer

Lancet. 2017 Jul 1;390(10089):3-4. doi: 10.1016/S0140-6736(17)31074-7. Epub 2017 May 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung
  • Humans
  • Lung Neoplasms*
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles*

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles

Associated data

  • ClinicalTrials.gov/NCT02075840
  • ClinicalTrials.gov/NCT02737501
  • ClinicalTrials.gov/NCT03052608